News
Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead
Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...
While Novo Nordisk say they're fighting against stigma, critics say they could be promoting prescription drugs under the ...
Novo Nordisk A/S (NYSE:NVO) is one of the Reddit Stocks with the Highest Upside Potential. On August 6, the company stated ...
Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...
Novo Nordisk said on Friday the US Food and Drug Administration has granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver ...
Wall Street loves a dominant player, and Eli Lilly (NYSE: LLY) looks unstoppable with its obesity blockbusters printing money ...
There's a spot in the £40m league phase resting on the double header and Thomas Buffel reckons it's a tough one to call.
Three years after President Joe Biden signed the Inflation Reduction Act, the Trump administration has significantly reduced ...
Eli Lilly and Company (NYSE:LLY)’s pipeline has been advancing, thanks to positive study results in oncology and ...
Secretary Francisco Tiu Laurel Jr. and National Irrigation Administration (NIA) Administrator Engr. Eddie Guillen led the NIA ...
Wegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver ...
AI-designed antibiotics show in vivo efficacy against multidrug-resistant N. gonorrhoeae and MRSA, offering a new approach to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results